Chunping Ye
123 Mochou Road
Nanjing, 210004, China
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies.
Journal: Cancer gene therapy
Published: December 30, 2025
FTO promotes the cervical cancer progression via regulation of FGF2 expression.
Journal: Annals of medicine and surgery (2012)
Published: August 04, 2025
Cohort-based pan-cancer analysis and experimental studies reveal ISG15 gene as a novel biomarker for prognosis and immunotherapy efficacy prediction.
Journal: Cancer immunology, immunotherapy : CII
Published: February 18, 2025
Corrigendum to "Thirdhand smoke exposure promotes gastric tumor development in mouse and human" [Environ. Int. 191 (2024) 108986].
Journal: Environment international
Published: October 06, 2024
Thirdhand smoke exposure promotes gastric tumor development in mouse and human.
Journal: Environment international
Published: March 01, 2024
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.
Journal: Materials today. Bio
Published: June 17, 2022
Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer.
Journal: Frontiers in immunology
Published: December 24, 2021
High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Journal: BMC cancer
Published: September 29, 2021
Lobaplatin Induces Pyroptosis in Cervical Cancer Cells via the Caspase-3/GSDME Pathway.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 25, 2021
A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo.
Journal: Biochemical and biophysical research communications
Published: March 02, 2019
Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.
Journal: Oncotarget
Published: July 12, 2017
ROR1 expression correlated with poor clinical outcome in human ovarian cancer.
Journal: Scientific reports
Published: March 21, 2014
Last Updated: 09/26/2026